5-methylcytosine has been researched along with Cancer of the Urinary Tract in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, CH; Chang, H; Chang, YH; Chen, WC; Chung, CJ; Chung, MC; Chuu, CP; Huang, CP; Yang, CR | 1 |
1 other study(ies) available for 5-methylcytosine and Cancer of the Urinary Tract
Article | Year |
---|---|
Reduced 5-methylcytosine level as a potential progression predictor in patients with T1 or non-invasive urothelial carcinoma.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Carcinoma; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Female; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Odds Ratio; Urologic Neoplasms; Urothelium | 2014 |